Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø

XClose

Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø News

Home
Menu

People with partial resistance to Alzheimer’s could inspire new drugs

16 May 2023

Dr Stephanie Fowler (Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø Queen Square Institute of Neurology) highlighted that treatments called antisense oligonucleotides are in development that reduce cells’ manufacturing of tau which play a key role in Alzheimer’s disease pathophysiology.